TEHRAN UNIVERSITY OF MEDICAL SCIENCES -  

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2019-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 6.906.583 371.376 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ASSOCIACAO FEMININA DE EDUCACAO E COMBATE AO CANCER1
AVIVIA BEHEER BV1
CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD1
CHARLES UNIVERSITY PRAGUE1
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
FUNDACAO ANTONIO PRUDENTE1
FUNDACAO PIO XII1
INSTITUT CATALA D'ONCOLOGIA1
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER1
KLINIKUM DER UNIVERSITAET ZU KOELN1
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER1
MINISTERIO DA SAUDE1
OBLITA THERAPEUTICS1
ST GEORGE'S HOSPITAL MEDICAL SCHOOL1
THE UNIVERSITY OF TENNESSEE1
THE UNIVERSITY OF TUEBINGEN1
UNIVERSIDAD DE BUENOS AIRES1
UNIVERSIDAD DE LA REPUBLICA1
UNIVERSIDAD EL BOSQUE1
UNIVERSITA DEGLI STUDI DI TORINO1
UNIVERSITY OF BRISTOL1
UNIVERSITY OF GLASGOW1

Constancy:

Total number of partners: 22
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 22
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2019-05-01Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis TT4CLparticipant3.753.1366
2019-01-01Translational studies of HEAD and neck cancer in South America and Europe HEADSpAcEparticipant3.153.44818